149 related articles for article (PubMed ID: 34340974)
1. Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical staging.
Tomar AS; Finger PT; Gallie B; Kivelä T; Mallipatna A; Zhang C; Zhao J; Wilson M; Brennan R; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganeshan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef Y; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada GL; Schaiquevich P; Fandiño AC; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa Llano M; Carreras E; ;
Br J Ophthalmol; 2023 Jan; 107(1):127-132. PubMed ID: 34340974
[TBL] [Abstract][Full Text] [Related]
2. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part II: Treatment Success and Globe Salvage.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Brenna RC; Burges M; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català J; Correa-Llano G; Carreras E;
Ophthalmology; 2020 Dec; 127(12):1733-1746. PubMed ID: 32526306
[TBL] [Abstract][Full Text] [Related]
3. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
4. Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based Study.
Tomar AS; Finger PT; Gallie B; Kivelä TT; Mallipatna A; Zhang C; Zhao J; Wilson MW; Brennan RC; Burges M; Kim J; Berry JL; Jubran R; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Volodin D; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Semenova E; Català-Mora J; Correa-Llano G; Carreras E;
Ophthalmology; 2022 Aug; 129(8):933-945. PubMed ID: 35500608
[TBL] [Abstract][Full Text] [Related]
5. Management and outcome of retinoblastoma with vitreous seeds.
Manjandavida FP; Honavar SG; Reddy VA; Khanna R
Ophthalmology; 2014 Feb; 121(2):517-24. PubMed ID: 24572675
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter, International Collaborative Study for American Joint Committee on Cancer Staging of Retinoblastoma: Part I: Metastasis-Associated Mortality.
Tomar AS; Finger PT; Gallie B; Mallipatna A; Kivelä TT; Zhang C; Zhao J; Wilson MW; Kim J; Khetan V; Ganesan S; Yarovoy A; Yarovaya V; Kotova E; Yousef YA; Nummi K; Ushakova TL; Yugay OV; Polyakov VG; Ramirez-Ortiz MA; Esparza-Aguiar E; Chantada G; Schaiquevich P; Fandino A; Yam JC; Lau WW; Lam CP; Sharwood P; Moorthy S; Long QB; Essuman VA; Renner LA; Català J; Correa-Llano G;
Ophthalmology; 2020 Dec; 127(12):1719-1732. PubMed ID: 32512116
[TBL] [Abstract][Full Text] [Related]
7. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.
Yousef YA; Mohammad M; Mehyar M; Sultan I; Al-Hussaini M; Alhourani J; Halalsheh H; Khzouz J; Jaradat I; Qaddoumi I; Al-Nawaiseh I
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e841-e847. PubMed ID: 33769386
[TBL] [Abstract][Full Text] [Related]
8. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
9. Management of Recurrence in Retinoblastoma Based on the Source of Tumor Cells.
Thaker SK; Shah PK; Das A; Maitra P
Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of recurrence of retinal tumors, vitreous seeds, and subretinal seeds following chemoreduction for retinoblastoma.
Shields CL; Honavar SG; Shields JA; Demirci H; Meadows AT; Naduvilath TJ
Arch Ophthalmol; 2002 Apr; 120(4):460-4. PubMed ID: 11934319
[TBL] [Abstract][Full Text] [Related]
11. Periocular topotecan for vitreous seeds in retinoblastoma.
Sthapit PR; Rao R; Honavar SG
Indian J Ophthalmol; 2018 Dec; 66(12):1833-1838. PubMed ID: 30451190
[TBL] [Abstract][Full Text] [Related]
12. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
13. Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma.
Berry JL; Bechtold M; Shah S; Zolfaghari E; Reid M; Jubran R; Kim JW
Ophthalmology; 2017 Dec; 124(12):1817-1825. PubMed ID: 28655537
[TBL] [Abstract][Full Text] [Related]
14. The role of external beam radiation therapy for retinoblastoma after failure of combined chemoreduction and focal consolidation therapy.
Yousef YA; Mohammad M; Jaradat I; Shatnawi R; Banat S; Mehyar M; Al-Nawaiseh I
Ophthalmic Genet; 2020 Feb; 41(1):20-25. PubMed ID: 32072842
[No Abstract] [Full Text] [Related]
15. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results.
Shields CL; Manjandavida FP; Arepalli S; Kaliki S; Lally SE; Shields JA
JAMA Ophthalmol; 2014 Mar; 132(3):319-25. PubMed ID: 24407202
[TBL] [Abstract][Full Text] [Related]
17. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
18. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
19. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
20. RETINOBLASTOMA ASSOCIATED WITH TOTAL EXUDATIVE RETINAL DETACHMENT: Treatment and Outcomes.
Ghose N; Agarwal P; Palkonda VAR; Kaliki S
Retina; 2023 May; 43(5):808-814. PubMed ID: 36728575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
